Semaglutide COA
- Version
- Download 5
- File Size 2.57 MB
- File Count 1
- Create Date June 26, 2026
- Last Updated June 26, 2026
Semaglutide COA
Certificate of Analysis (COA) – Semaglutide – Batch 202605
AI Overview Summary
This Certificate of Analysis (COA) documents the batch-specific analytical verification of Semaglutide Batch 202605 under laboratory quality control conditions. Testing includes HPLC purity analysis, LC-MS identity confirmation, and optional third-party validation by SENO Test Center. The report provides structured batch-level traceability and laboratory documentation for research-grade use only.
Batch Information
| Field | Specification |
|---|---|
| Product Name | Semaglutide |
| Batch ID | 202605 |
| Brand | RPL Peptide |
| Category | Research Peptide / Metabolic Research Reagent |
| Production Status | Released for Laboratory Distribution |
| Quality Status | Internal QC Passed + Third-Party Validation (if applicable) |
| Third-Party Laboratory | SENO Test Center |
| COA ID | COA-SEM-202605 |
| Intended Use | Laboratory Research Use Only |
Analytical Verification Summary
| Test | Method | Instrument / Lab | Result | Status |
|---|---|---|---|---|
| Purity Analysis | HPLC | Internal QC Laboratory | ≥98.0% | Pass |
| Identity Confirmation | LC-MS | Internal QC Laboratory | Consistent with Reference Standard | Pass |
| Chromatographic Profile | UPLC | Internal QC Laboratory | Within Specification | Pass |
| Optional Third-Party Validation | Cross Verification | SENO Test Center | Confirmed Analytical Consistency | Pass |
| Final QC Review | Batch Release Audit | RPL QC System | Approved | Released |
Certificate of Analysis Documentation
A Certificate of Analysis (COA) is a controlled laboratory document providing batch-specific analytical results, identity verification, and quality control status for research materials.
For Semaglutide Batch 202605, the COA includes:
- Batch identifier and production record
- HPLC purity assessment
- LC-MS molecular identity confirmation
- UPLC chromatographic profiling
- Internal QC review results
- Optional third-party validation (SENO Test Center)
- Batch traceability linkage
Batch Traceability System
Each Semaglutide batch is assigned a unique identifier linking:
- Manufacturing records
- Analytical testing data
- Internal QC documentation
- Third-party validation reports
- COA issuance record
This ensures full lifecycle traceability from production to laboratory documentation and quality control review.
Download COA
📄 Download Certificate of Analysis (COA PDF – Semaglutide Batch 202605)
File Size: 2.53 MB
Last Updated: June 26, 2026
Frequently Asked Questions (FAQ)
What is a Certificate of Analysis (COA)?
A COA is a batch-specific laboratory document containing analytical test results, quality control verification, and release status for research materials.
What is Semaglutide?
Semaglutide is a research-grade biochemical reagent used in metabolic signaling and receptor interaction research. It is not intended for human or veterinary use.
Which analytical methods are used in this COA?
Analytical methods include HPLC for purity analysis, LC-MS for identity confirmation, and UPLC for chromatographic profiling.
What is SENO Test Center?
SENO Test Center is a third-party analytical laboratory used to validate batch consistency and confirm analytical results independently.
Is this COA batch-specific?
Yes. Each COA is generated for a specific production batch and cannot be applied to other batches.
What is batch traceability?
Batch traceability refers to the system that links manufacturing records, analytical data, and quality control documentation for each production batch.
Is Semaglutide intended for human use?
No. Semaglutide is supplied strictly as a research-grade laboratory reagent for scientific research only.